Tyndall Mark Anthony — SEC Form 4 filings

SEC reporting owner CIK 1944622. 5 Form 4 filings on record with FilingPulse; latest filed 2026-02-26.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-06 to 2026-02-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Keenova Therapeutics plcEVP & CLO and Corp Sec59

Form 4 filings — Tyndall Mark Anthony

FiledFormIssuerReported transactionsSource
2026-02-264Keenova Therapeutics plcGrant/award (A): 51,794 (derivative) @ $0EDGAR
2026-01-054Keenova Therapeutics plcOption exercise (M): 6,576 · Tax withholding (F): 2,107 · Option exercise (M): 6,576 (derivative) @ $0EDGAR
2025-08-044Mallinckrodt plcGrant/award (A): 32,828 (derivative) @ $0EDGAR
2025-01-024Mallinckrodt plcOption exercise (M): 5,470 · Tax withholding (F): 1,772 · Option exercise (M): 5,470 (derivative) @ $0EDGAR
2024-02-064Mallinckrodt plcGrant/award (A): 16,413 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1944622 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →